SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-19-002224
Filing Date
2019-11-07
Accepted
2019-11-07 07:05:58
Documents
13
Period of Report
2019-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K a52124251.htm   iXBRL 8-K 33743
2 EXHIBIT 99.1 a52124251ex99_1.htm EX-99.1 7910
  Complete submission text file 0001157523-19-002224.txt   191058

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20191107.xsd EX-101.SCH 4389
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20191107_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20191107_pre.xml EX-101.PRE 16832
10 EXTRACTED XBRL INSTANCE DOCUMENT a52124251_htm.xml XML 4471
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 191198098
SIC: 2834 Pharmaceutical Preparations